Small molecule drug substance and development remain the backbone of complex therapeutic programs — and knowing where to find the right expertise has never been more critical. That’s why the Outsourced Pharma Capacity Update has evolved into the Outsourced Pharma Capabilities Update (OPCU) — a series designed to go beyond capacity and highlight the real differentiators: the technologies, experience, and specialized capabilities CDMOs bring to your programs.
Across these sessions, you’ll get a clear view into the most critical stages of development — and how the right partners can help reduce cycle times, strengthen quality, and de-risk scale-up for small molecule assets.
Tune in each month to our expanded PARTNER WEEK, organized by capability area, which makes it easier than ever to pinpoint the right CDMO strengths — exactly when you need them.
Recent Sessions Available On-Demand
Large Molecule – 3/10/2026, AM Session
Fill / Finish – 3/10/2026, PM Session
Upcoming OPCU Topics & Times
Small Molecule Drug Product | 4/21/2026, AM Session
Fill/Finish | 4/22/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
